[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100647278":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":29,"locations":17,"responsibleParty":38,"collaborators":17,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":17,"eligibilityCriteria":48,"healthyVolunteers":49,"sex":50,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":17,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":63,"overallStatus":66,"whyStopped":17,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":17},{"fullName":5,"class":6},"Rutgers, The State University of New Jersey","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Repeat glucose tolerance test (GTT) with continuous glucose monitor","EXPERIMENTAL","Group 1 will undergo a repeat glucose tolerance test (GTT) with blinded continuous glucose monitor (CGM). Patients will receive nutrition counseling as this would be standard in patients at high risk for gestational diabetes. The CGM sensor will collect glycemic data over 10 consecutive days, with up to 20 days of CGM data per patient, ie they will wear two 10-day CGMs in total. The patients in group 1, as well as the researchers and the patient's provider will know the patient is wearing a CGM, however the CGM data will be blinded until the patient delivers.",[13],"Diagnostic Test: Glucose tolerance test and continuous glucose monitor",{"label":15,"type":16,"description":17,"interventionNames":17},"Control group","NO_INTERVENTION",null,[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":17},"DIAGNOSTIC_TEST","Glucose tolerance test and continuous glucose monitor","1. Glucose tolerance test\n2. Continuous glucose monitoring for two weeks\n3. Nutrition counseling",[9],[25],{"name":26,"affiliation":27,"role":28},"Shauna Williams, MD","Rutgers Health New Jersey Medical School","PRINCIPAL_INVESTIGATOR",[30,35],{"name":31,"role":32,"phone":33,"phoneExt":17,"email":34},"Rebecca Bradley, DO","CONTACT","973-862-5262","rlb310@njms.rutgers.edu",{"name":26,"role":32,"phone":36,"phoneExt":17,"email":37},"973-972-5262","williash@njms.rutgers.edu",{"type":39,"investigatorFullName":40,"investigatorTitle":41,"investigatorAffiliation":5,"oldNameTitle":17,"oldOrganization":17},"SPONSOR_INVESTIGATOR","Shauna F. Williams, MD","Principal investigator","100647278","repeat-late-gdm-testing-and-cesarean-delivery-rates-100647278",false,"NCT07708129","Repeat Late GDM Testing and Cesarean Delivery Rates","Impact of Late Gestational Diabetes Detection and Treatment on Cesarean Delivery Rates After Negative Initial Screening","Inclusion Criteria:\n\n* Gestational age 30 weeks 0 days and 36 weeks 6 days\n* Ultrasound with estimated fetal weight or abdominal circumference greater than 90th%ile\n* Age 18-50 years old.\n\nExclusion Criteria:\n\n* Previously diagnosed gestational diabetes or pre-gestational diabetes\n* Multiple gestation\n* Previous cesarean delivery\n* Any condition precluding vaginal delivery (placenta previa\u002Fplacenta accreta spectrum disorders, vasa previa, prior uterine surgery with contraindication to vaginal delivery)\n* Suboptimal dating (based on US \\>22wk gestation)\n* Contraindication to glucose tolerance test",true,"FEMALE","18 Years","50 Years",{"count":54,"type":55},144,"ESTIMATED","INTERVENTIONAL",[58],"NA","The goal of this randomized trial is determine if re-testing for gestational diabetes in the third trimester after an ultrasound measurement of estimated fetal weight (EFW) or abdominal circumference greater than 90%ile decreases cesarean delivery rate, and to evaluate the optimal method of re-testing. The main question it aims to answer is:\n\nDoes repeat testing for gestational diabetes and management of hyperglycemia decrease the cesarean delivery rate in fetuses measuring \\>90%ile by estimated fetal weight (EFW) or abdominal circumference (AC) on ultrasound in the third trimester.\n\nParticipants will be randomized into two groups: Group 1 will undergo a repeat glucose tolerance test (GTT) with blinded continuous glucose monitor (CGM) and group 2 will have no intervention. Participants in group 1 will receive nutrition counseling as this would be standard in patients at high risk for gestational diabetes.",[61,62],"Large for Gestational Age (LGA)","Pregnancy",[64,65,62],"Large for gestational age","Ultrasound","NOT_YET_RECRUITING","2026-07-12",{"date":69,"type":70},"2026-07-16","ACTUAL",{"date":72,"type":55},"2026-08-01",{"date":74,"type":55},"2028-05-31",{"name":40,"class":6}]